AstraZeneca PLC (LON:AZN)
London · Delayed Price · Currency is GBP · Price in GBX 13,484
-128 (-0.94%)
Dec 16, 2025, 3:40 PM BST
AstraZeneca Market Cap
AstraZeneca has a market cap or net worth of 211.08 billion as of December 16, 2025. Its market cap has increased by 29.92% in one year.
Market Cap
211.08B
Enterprise Value
229.36B
Revenue
43.24B
Ranking
n/a
PE Ratio
30.40
Stock Price
13,484.00
Market Cap Chart
Since May 28, 1993, AstraZeneca's market cap has increased from 4.55B to 211.08B, an increase of 4,538.82%. That is a compound annual growth rate of 12.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 15, 2025 | 211.08B | 30.07% |
| Dec 31, 2024 | 162.29B | -1.22% |
| Dec 29, 2023 | 164.29B | -5.48% |
| Dec 30, 2022 | 173.83B | 29.30% |
| Dec 31, 2021 | 134.44B | 39.83% |
| Dec 31, 2020 | 96.14B | -3.67% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| GSK plc | 73.26B |
| Haleon | 31.93B |
| Smith & Nephew | 10.33B |
| Convatec Group | 4.48B |
| Hikma Pharmaceuticals | 3.36B |
| HUTCHMED (China) | 1.75B |
| Genus | 1.67B |
| Oxford Nanopore Technologies | 1.20B |